Bio&Me, the UK fibre and gut-health brand launched in 2019, has moved into profitability and is signalling a shift in growth strategy toward repeat customers rather than shelf expansion alone.
Co-founder and CEO Jon Walsh told Just Food the company expects to hit £20 million in sales this year, representing 45% year-on-year growth. Growth is now being driven by repeat purchase rates climbing above 40% on key product lines, moving away from a model where "the majority of our growth came from distribution gains." Sales currently run 95% through supermarkets, with expansion into e-commerce and new drinks categories flagged as opportunities.
Walsh positioned gut health as a durable consumer trend rather than a fad, citing seven years of steady growth accelerated by COVID and social media interest in "fibremaxxing." His own research suggests 34% of consumers show interest in gut health, split between a small highly informed segment of 2 to 4% and a larger 30% seeking simple, actionable guidance.
The company raised £4.5 million over its first five years but has not sought funding for the past two years as it achieved break-even status in the second half of last year. Walsh said Bio&Me will stay focused on the UK market for now, though the leadership is "properly looking at" international expansion. Future growth levers include branded marketing, NPD around granolas, and a new partnership with Bowel Cancer UK.
Bio&Me has held prices carefully. Over seven years it has implemented only one price increase, following the Ukraine conflict, while rivals in cereal have pushed through four or five. The company operates on a small premium of about 10% above mainstream granola brands, which Walsh attributes to "better ingredients for gut health." Distribution spans lower-cost retailers such as Asda and Morrisons as well as premium channels, with Walsh stressing the ambition to be "mainstream" rather than serving only affluent shoppers.